𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Enteral nutrition—The new maintenance therapy in Crohn's disease?

✍ Scribed by Herbert Lochs

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
52 KB
Volume
13
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enteral nutrition in adult Crohn's disea
Enteral nutrition in adult Crohn's disease: Present status and perspectives
✍ Benoît Dupont; Claire Dupont; Anne-Marie Justum; Marie-Astrid Piquet; Jean-Marie 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

## Abstract Enteral nutrition has long been a therapeutic alternative often used in adult Crohn's disease patients to obtain remission or clinical response, especially in those not responding to conventional therapy such as corticosteroids. However, the increasing use of immunosuppressors (6‐mercap

Osteoprotegerin in pediatric Crohn's dis
Osteoprotegerin in pediatric Crohn's disease and the effects of exclusive enteral nutrition
✍ Lily Nahidi; Steven T. Leach; Marc A. Sidler; Alon Levin; Daniel A. Lemberg; And 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

Background: Osteoprotegerin (OPG) may have proinflammatory roles in addition to its contribution to the maintenance of bone mass. Exclusive enteral nutrition (EEN) is an established therapy for the induction of remission in Crohn's disease (CD). The aims of this study were to ascertain serum, fecal,

Long-term outcome of maintenance inflixi
Long-term outcome of maintenance infliximab therapy in children with Crohn's disease
✍ Jeffrey S. Hyams; Trudy Lerer; Anne Griffiths; Marian Pfefferkorn; Subra Kugatha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 2 views

Background: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. ## Methods: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled i

Nutritional therapy for Crohn's disease:
Nutritional therapy for Crohn's disease: Lessons from the Ste.-Justine hospital experience
✍ Dr. Ernest Seidman 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 1 views

The good physician is he who knows how to choose the right remedies at the proper time-Aeschylus (525-456 BC) or Why do nice patients fail to respond to appropriate treatment plans? E. Seidman (DDW [Digestive Disease Week] IBD Forum, San Francisco, 1992) ## THE RATIONALE FOR NUTRITIONAL THERAPY C

Mucosal healing predicts long-term outco
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease
✍ Fabian Schnitzler; Herma Fidder; Marc Ferrante; Maja Noman; Ingrid Arijs; Gert V 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 2 views

Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease (CD) but the impact of MH on the long-term outcome of IFX treatment in CD is still debated. ## Methods: We studied MH during long-term treatment with IFX in 214 CD patients. A total of 183 patients